Home
About Us
Our Vision & Mission
Who We Are
Our History
Message from CMD-Desk
Our Leadership
People and Values
Our Values
Testimonials
Our Major Accreditations
Meet Our Team
Our Partners
Our Business
Ethical Business
Generic Healthcare Business
Export Business
Research & Development
Products
Ethical
Allopathic Medicine
General Health
Gynaecology
Pediatric
Ayurvedic Medicine
Generic
Agile
Healthcare
Capacities
Quality
Manufacturing
Global Business Unit
Samba Unit
Research & Development
Investor Relations
Disclosure under Regulation 46
Details of Business
MOA
Composition & Brief Profile of Directors
Composition of Committees
Corporate Goverance
Notice of Board Meetings
Financial Results (Quarterly)
Credit Rating
Audited Financial Results of Subsidiaries
Annual Returns
Notice of AGM/EGM
Notices
Annual Reports
Voting Results
Transcript
Business Responsiblity Reports
Shareholders Information
Shareholder Services
Unclamied Dividend
Details of Transfer under SEBI Circular
Amalgamation
Preferential Issue
Corporate Announcements
Integrated Corporate Goverance
Shareholding Pattern
Other Announcements
Publications
Regulation 30
Related Party Transactions
Regulation 47
Responsibility
Sustainability
CSR
EHS
Opportunities
Join Us
Careers
Contact Us
Location
SCO 850, Shivalik Enclave, Sector 13, NAC Manimajra, Chandigarh - 160101
Phone
0172-5061850
Email
support@indswiftlabs.com
Home
Disclaimer
Call us:
0172-5061850
Email us:
support@indswiftlabs.com
Regd. Office:
SCO 850, Shivalik Enclave, Sector 13, NAC Manimajra, Chandigarh - 160101
Home
About Us
Our Vision & Mission
Who We Are
Our History
Message from CMD-Desk
Our Leadership
People and Values
Our Values
Testimonials
Our Major Accreditations
Meet Our Team
Our Partners
Our Business
Ethical Business
Generic Healthcare Business
Export Business
Research & Development
Products
Ethical
Allopathic Medicine
General Health
Gynaecology
Pediatric
Ayurvedic Medicine
Generic
Agile
Healthcare
Capacities
Quality
Manufacturing
Global Business Unit
Samba Unit
Research & Development
Investor Relations
Disclosure under Regulation 46
Details of Business
MOA
Composition & Brief Profile of Directors
Composition of Committees
Corporate Goverance
Notice of Board Meetings
Financial Results (Quarterly)
Credit Rating
Audited Financial Results of Subsidiaries
Annual Returns
Notice of AGM/EGM
Notices
Annual Reports
Voting Results
Transcript
Business Responsiblity Reports
Shareholders Information
Shareholder Services
Unclamied Dividend
Details of Transfer under SEBI Circular
Amalgamation
Preferential Issue
Corporate Announcements
Integrated Corporate Goverance
Shareholding Pattern
Other Announcements
Publications
Regulation 30
Related Party Transactions
Regulation 47
Responsibility
Sustainability
CSR
EHS
Opportunities
Join Us
Careers
Contact Us
Home
About Us
Our Vision & Mission
Who We Are
Our History
Message from CMD-Desk
Our Leadership
People and Values
Our Values
Testimonials
Our Major Accreditations
Meet Our Team
Our Partners
Our Business
Ethical Business
Generic Healthcare Business
Export Business
Research & Development
Products
Ethical
Allopathic Medicine
General Health
Gynaecology
Pediatric
Ayurvedic Medicine
Generic
Agile
Healthcare
Capacities
Quality
Manufacturing
Global Business Unit
Samba Unit
Research & Development
Investor Relations
Disclosure under Regulation 46
Details of Business
MOA
Composition & Brief Profile of Directors
Composition of Committees
Corporate Goverance
Notice of Board Meetings
Financial Results (Quarterly)
Credit Rating
Audited Financial Results of Subsidiaries
Annual Returns
Notice of AGM/EGM
Notices
Annual Reports
Voting Results
Transcript
Business Responsiblity Reports
Shareholders Information
Shareholder Services
Unclamied Dividend
Details of Transfer under SEBI Circular
Amalgamation
Preferential Issue
Corporate Announcements
Integrated Corporate Goverance
Shareholding Pattern
Other Announcements
Publications
Regulation 30
Related Party Transactions
Regulation 47
Responsibility
Sustainability
CSR
EHS
Opportunities
Join Us
Careers
Contact Us
Regulation 47
Home
Investor Relations
Regulation 47
Publication of Financial Results for FY Ended 31.03.2025 in Financial Express —
[Download 674Kb]
Publication of Financial Results for FY Ended 31.03.2025 in Jansatta Newspaper —
[Download 284Kb]
Re-lodgement of Physical Share Circular 02.07.2025 —
[Download 1.27Mb]
AGM Newspaper Publication 07.09.2023 —
[Download 6.90Mb]
EGM Newspaper Publication 14.09.2023 —
[Download 7.49Mb]
AGM Newspaper Publication 31.08.2023 —
[Download 8.5Mb]
AGM Newspaper Publication 08.09.2022 —
[Download 7.15Mb]
AGM Newspaper Publication 01.09.2022 —
[Download 1.15Mb]
Newspaper Results 31.03.2022 —
[Download 487Kb]
Newspaper Publication FY 2021-22 —
[Download 1.29Mb]
Newspaper Notice AGM-2021 —
[Download 520Kb]
Newspaper Notice EGM-2021 —
[Download 546Kb]
Newspaper Notice 25th AGM 07.11.2020—
[Download 2.3Mb]
Newspaper Notice 24th AGM 09.11.2019 —
[Download 620Kb]
